CLRO is trading 16.16% down today at $11.60 as momentum cools following an extended, high-volatility surge tied to the Cortigent reverse-merger announcement.
- The move appears to be driven by profit-taking and cooling momentum rather than new company-specific headlines.
- Broader markets are also softer, with the S&P 500 down 0.57% and the Nasdaq down 0.46%.